Hyo J. Son
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Mesenchymal Stem Cells With Adjuvant Dexamethasone in Patients With Alzheimer's Disease: A Phase IIa Trial.
Journal: Dementia and neurocognitive disorders
Published: August 20, 2025
ACE inhibition increases Alzheimer's disease risk by promoting tau phosphorylation.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025
Intracerebroventricular human mesenchymal stem cells induce MMP9-driven transient inflammation in Alzheimer's disease.
Journal: Stem cell research & therapy
Published: August 07, 2025
Targeted autophagic clearance of Tau protects against Alzheimer's disease through amelioration of Tau-mediated lysosomal stress.
Journal: Theranostics
Published: May 28, 2025
Polygenic risk score of Alzheimer's disease is associated with cognitive trajectories and phenotypes of cerebral organoids.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 11, 2025
Author Correction: Clinical spectrum of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia in individuals of Korean ancestry.
Journal: Scientific reports
Published: March 19, 2025
Effects of Dexamethasone and Tacrolimus on Mesenchymal Stem Cell Characteristics and Gene Expression.
Journal: International journal of stem cells
Published: October 22, 2024
Clinical spectrum of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia in individuals of Korean ancestry.
Journal: Scientific reports
Published: June 06, 2024
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: January 04, 2024
Correction: Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism.
Journal: Molecular psychiatry
Published: October 02, 2023
Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer's disease.
Journal: Stem cell research & therapy
Published: July 01, 2022
Combination of Dexamethasone and Tofacitinib Reduces Xenogeneic MSC-Induced Immune Responses in a Mouse Model of Alzheimer's Disease.
Journal: Biomedicines
Published: June 29, 2022
Last Updated: 09/26/2026